Skip to main navigation Skip to search Skip to main content

Correction: Dumbuya et al. Exploring disulfiram’s anticancer potential : PLGA nano-carriers for prolonged drug delivery and potential improved therapeutic efficacy. Nanomaterials 2024, 14, 1133

  • Ibrahim Dumbuya
  • , Ana Maria Pereira
  • , Ibrahim Tolaymat
  • , Adnan Al Dalaty
  • , Basel Arafat
  • , Matt Webster
  • , Barbara Pierscionek
  • , Mouhamad Khoder
  • , Mohammad Najlah
  • Anglia Ruskin University
  • GMPriority Pharma Ltd.
  • University of Winchester

Research output: Contribution to journalArticlepeer-review

Abstract

In the original publication [1], the reference [1], “Kashyap, D.; Pal, D.; Sharma, R.; Garg, V.K.; Goel, N.; Koundal, D.; Zaguia, A.; Koundal, S.; Belay, A. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. BioMed Res. Int. 2022, 2022, 9605439” was retracted prior to this publication, and the authors would like to replace it with the reference “Sung, H.; Ferlay, J.; Siegel, R.L.; Laversanne, M.; Soerjomataram, I.; Jemal, A.; Bray, F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2021, 71, 209–249”. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Original languageEnglish
Article number1619
JournalNanomaterials
Volume15
Issue number21
Early online date23 Oct 2025
DOIs
Publication statusPublished - Nov 2025

Fingerprint

Dive into the research topics of 'Correction: Dumbuya et al. Exploring disulfiram’s anticancer potential : PLGA nano-carriers for prolonged drug delivery and potential improved therapeutic efficacy. Nanomaterials 2024, 14, 1133'. Together they form a unique fingerprint.

Cite this